SCHEMBL77840

SCHEMBL77840

N#CC(C#N)=C1C=CC=CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15068302 0.69
SCHEMBL9695405 0.64 KDM4E (0.31)
SCHEMBL234874 0.60
SCHEMBL4803231 0.60 ALDH1A1 (0.34)
SCHEMBL2125649 0.59
SCHEMBL3340071 0.59 CA1 (0.36)
SCHEMBL2125651 0.59
SCHEMBL170080 0.59
SCHEMBL3372716 0.59
SCHEMBL2876269 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2712 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3661539-B1 OPTIMIZED PEPTIDES FOR TARGETING HUMAN NERVES AND THEIR USE IN IMAGE GUIDED SURGERY, DIAGNOSTICS AND THERAPEUTIC DELIVERY UNIV CALIFORNIA (US) 2024-10-09 EP claimed
WO-2024155728-A1 NANOPARTICLES AND METHODS OF USE QANA THERAPEUTICS INC. (US) 2024-07-25 WO claimed
US-20240207421-A1 NERVE TARGETING PEPTIDES AND METHODS OF USE ALUME BIOSCIENCES INC (US) 2024-06-27 US claimed
CN-111246873-B Optimized peptides for targeting human nerves and their use in image guided surgery, diagnosis and therapy delivery 加利福尼亚大学董事会 2024-03-01 CN claimed
US-11802138-B2 Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostic and therapeutic delivery THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-31 US claimed
CN-116916971-A Methods and compositions for ureter visualization in surgical procedures 阿鲁莫生物科学公司 2023-10-20 CN claimed
WO-2022155385-A1 METHODS AND COMPOSITIONS FOR VISUALIZING A URETER IN A SURGICAL PROCEDURE ALUME BIOSCIENCES, INC. (US) 2022-07-21 WO claimed
WO-2022120177-A1 NERVE TARGETING PEPTIDES AND METHODS OF USE ALUME BIOSCIENCES, INC. (US) 2022-06-09 WO claimed
US-11299515-B2 Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-04-12 US claimed
CN-111246873-A Optimized peptides for targeting human nerves and their use in image-guided surgery, diagnosis and therapy delivery 加利福尼亚大学董事会 2020-06-05 CN claimed
EP-1001475-A2 Method of making an organic lightemitting device EASTMAN KODAK COMPANY (US) 2000-05-17 EP claimed
US-6048573-A Method of making an organic light-emitting device EASTMAN KODAK COMPANY (US) 2000-04-11 US claimed
US-5989737-A Organic electroluminescent devices XEROX CORPORATION (US) 1999-11-23 US claimed
US-5846666-A Electroluminescent devices XEROX CORPORATION (US) 1998-12-08 US claimed
US-5405709-A White light emitting internal junction organic electroluminescent device EASTMAN KODAK COMPANY (US) 1995-04-11 US claimed
EP-0643549-A1 White light emitting internal junction organic electroluminescent device EASTMAN KODAK COMPANY (US) 1995-03-15 EP claimed
EP-0281381-B1 ELECTROLUMINESCENT DEVICE WITH MODIFIED THIN FILM LUMINESCENT ZONE EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1992-07-15 EP claimed
EP-0349265-A2 Electroluminescent devices EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1990-01-03 EP claimed
EP-0341567-A2 Novel benzofuran dyes EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1989-11-15 EP claimed
US-4769292-A Electroluminescent device with modified thin film luminescent zone EASTMAN KODAK COMPANY (US) 1988-09-06 US claimed